Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128858) titled 'Efficacy and Safety of Letermovir Versus Preemptive Therapy for Preventing Cytomegalovirus Infection in Patients with Lymphoid Malignancies: A Clinical Study' on July 27.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
Lymphoid malignancies
Intervention:
Control group:blood CMV viral load was monitored once weekly, and preemptive antiviral treatment with ganciclovir was initiated as soon as a pre-specified virologic
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enr...